The Princeton IV Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular Disease.


Journal

Mayo Clinic proceedings
ISSN: 1942-5546
Titre abrégé: Mayo Clin Proc
Pays: England
ID NLM: 0405543

Informations de publication

Date de publication:
07 Aug 2024
Historique:
received: 08 04 2024
revised: 30 05 2024
accepted: 05 06 2024
medline: 8 8 2024
pubmed: 8 8 2024
entrez: 8 8 2024
Statut: aheadofprint

Résumé

The Princeton Consensus (Expert Panel) Conference is a multispecialty collaborative symposium dedicated to optimizing sexual function and preserving cardiovascular health. The Fourth Princeton Consensus Conference was convened on March 10-11, 2023, at the Huntington Medical Research Institutes in Pasadena, California. Princeton panels I to III addressed the clinical management of men with erectile dysfunction (ED) who also had cardiovascular disease. Thirteen years since Princeton III, Princeton IV builds on previous foundations in several key areas. Mounting evidence supports the need for providers to treat men with ED as being at risk for cardiac events until proven otherwise. Algorithms for the diagnosis and treatment of ED are updated with new recommendations for coronary artery calcium scoring for advanced cardiovascular risk stratification. Optimization of oral phosphodiesterase type 5 inhibitors in the treatment of men with ED and cardiovascular disease is thoroughly explored, including recent evidence of potential cardioprotective effects of these drugs.

Identifiants

pubmed: 39115509
pii: S0025-6196(24)00276-3
doi: 10.1016/j.mayocp.2024.06.002
pii:
doi:

Types de publication

Journal Article Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Auteurs

Tobias S Köhler (TS)

Department of Urology, Mayo Clinic, Rochester, MN. Electronic address: kohler.tobias@mayo.edu.

Robert A Kloner (RA)

Department of Cardiovascular Research, Huntington Medical Research Institutes, Pasadena, CA; Department of Medicine, Keck School of Medicine at University of Southern California, Los Angeles.

Raymond C Rosen (RC)

Department of Psychiatry and Behavioral Sciences, University of California, San Francisco.

Arthur L Burnett (AL)

Department of Urology, Johns Hopkins University, Baltimore, MD.

Michael J Blaha (MJ)

Cardiology and Epidemiology, John Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Baltimore, MD.

Peter Ganz (P)

Department of Medicine, University of California, San Francisco.

Irwin Goldstein (I)

Department of Sexual Medicine, Institute for Sexual Medicine, Alvarado Hospital, San Diego, CA.

Noel N Kim (NN)

Department of Sexual Medicine, Institute for Sexual Medicine, Alvarado Hospital, San Diego, CA.

Tom Lue (T)

Department of Urology, University of California, San Francisco.

Kevin T McVary (KT)

Center for Male Health, Stritch School of Medicine at Loyola University Medical Center, Maywood, IL.

John P Mulhall (JP)

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.

Sharon J Parish (SJ)

Weill Cornell Medicine, New York, NY; Department of Medicine and Psychiatry, Westchester Behavioral Health Center, NewYork-Presbyterian Hospital, White Plains, NY.

Hossein Sadeghi-Nejad (H)

Department of Urology, NYU Langone Grossman School of Medicine, New York, NY.

Richard Sadovsky (R)

Department of Family and Community Medicine, SUNY Downstate Health Sciences University, Brooklyn, NY.

Ira D Sharlip (ID)

Department of Urology, University of California, San Francisco.

Martin Miner (M)

Men's Health Center, Miriam Hospital, Providence, RI.

Classifications MeSH